GLP-1 agonist drugs are most often used to help type 2 diabetes patients lower their blood sugars or to help patients with heart disease prevent heart attacks or strokes, but some also can help treat obesity and soon could be approved for sleep apnea and other treatments
"The 44% reduction in all-cause mortality observed among patients with obesity and co-occurring autoimmune disease is a striking finding that demands our attention, said Fatima Cody Stanford, M.D., M.P.H., M.P.A., M.B.A., FAHA and member of the American Heart Associations Lifestyle and Cardiometabolic Council
Category 3: Medical necessity not established (10% of denials) BMI below threshold Insufficient duration of prior treatment attempts Contraindication present (family history of medullary thyroid cancer, pregnancy) Solution: If clinical facts support coverage, file a formal appeal
Secosan C, Balint O, Pirtea L, Grigoras D, Balulescu L, Ilina R
With our deep scientific foundation, our ambition is to be the most evidence-based and transformative food company in the world you can trust your gut with us.